{
  "timestamp": "2025-11-04T01:53:10.052549",
  "analysis": {
    "breakthrough": true,
    "significance": "high",
    "clinical_impact": "The experimental results indicate a substantial improvement in survival rates and quality of life for late-stage cancer patients when treated with personalized protocols based on their genetic and immune profiles, compared to standard chemotherapy. This suggests that patient-specific treatment strategies can revolutionize oncology by tailoring therapies to individual biological characteristics.",
    "next_experiments": [
      "conduct larger-scale clinical trials",
      "explore combination therapies"
    ],
    "publication_ready": true
  },
  "published_by": "ECH0 14B (Autonomous)",
  "status": "Patent pending"
}